polymerase beta. J. Biol.
Chem. 278(20):18471-18477.
Turturro, F., et al. (2002) Model of inhibition of the NPM-ALK kinase activity by herbimycin A. Clin.
Cancer Res. 8(1):240-245 (cites the use of this
other use of the CMV promoter requires a license from the University
of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242, USA.
Use of IRES is covered by U.S. Patent 4
other use of the CMV promoter requires a license from the University
of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242, USA.
Use of IRES is covered by U.S. Patent 4
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
peptide 19 C6930 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 M y n/d n/d
215 DAP Kinase 2
n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 NP_004929.2 M y n/d n/d
215 DAP Kinase
n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 NP_004929.2 M y n/d n/d
215 DAP Kinase